CTOs on the Move

Nkarta Therapeutics

www.nkartatx.com

 
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nkartatx.com
  • 6000 Shoreline Court Suite 102
    South San Francisco, CA USA 94080
  • Phone: 650.215.0385

Executives

Name Title Contact Details
Ralph Brandenberger
Senior Vice President of Technical Operations Profile
Ralph Brandenberger
Chief Technical Officer Profile

Funding

Nkarta Therapeutics raised $114M on 09/04/2019

Similar Companies

World Medical Solutions

World Medical Solutions is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sandy Springs Fitness

Sandy Springs Fitness is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phil

Phil is a B2B2C platform that connects patients, pharmacies, prescribers, and manufacturers in the specialty prescription ecosystem. We build software solutions & end-to-end services to power the $320B industry.

Delphinus Medical Technologies

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.

Definity Health

Definity Health is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.